Home / Business and Economy / India Pharma Exports Hit $30.47B, Eye Global Growth
India Pharma Exports Hit $30.47B, Eye Global Growth
7 Jan
Summary
- Pharmaceutical exports reached $30.47 billion in FY 2024-25.
- India ranks fourth among all export promotion councils.
- Domestic market projected to grow to $130 billion by 2030.
India's pharmaceutical sector has achieved a significant milestone, with exports reaching USD 30.47 billion in FY 2024-25, reflecting a robust 9.4 percent year-on-year increase. This performance positions India's pharmaceutical exports strongly for continued growth in the current fiscal year, underscoring the nation's sustained momentum in the global market.
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) engaged in high-level discussions with government officials to align policies and strategize for enhanced global market penetration. These engagements also emphasized fostering industry-academia collaboration and supporting Micro, Small, and Medium Enterprises (MSMEs) to further drive export figures.
Looking ahead, the domestic pharmaceutical market is anticipated to expand from its current valuation of approximately USD 60 billion to USD 130 billion by 2030. With India already being the world's third-largest producer by volume, these efforts aim to reinforce its standing as a trusted global supplier of affordable and quality medicines.
